Clinical pharmacokinetics of pregabalin in healthy volunteers.
about
Pregabalin for the treatment of generalized anxiety disorder: an updateClinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgiaPregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failurePregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Pregabalin: a review of its use in adults with generalized anxiety disorder.Abuse Potential of Pregabalin: A Systematic Review.Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.Factors predicting adverse events associated with pregabalin administered for neuropathic pain reliefPopulation pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers.Comparative study between 2 different doses of pregabalin and lidocaine on pain following propofol injection: A double-blind, randomized clinical consort study.Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region.Pregabalin for the treatment of postsurgical pain.The use of newer antiepileptic drugs in patients with renal failure.Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.ADMET considerations for restless leg syndrome drug treatments.Pregabalin for alcohol dependence: a critical review of the literature.Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.Understanding the pharmacokinetics of anxiolytic drugs.Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation.Spinal Reflexes and Windup In Vitro: Effects of Analgesics and Anesthetics.Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use.Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder.Comparison of oral absorption models for pregabalin: usefulness of transit compartment model.The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women.A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults.NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity.Silicon-containing GABA derivatives, silagaba compounds, as orally effective agents for treating neuropathic pain without central-nervous-system-related side effects.Pregabalin- and azithromycin-induced rhabdomyolysis with purpura: An unrecognized interaction: A case reportPharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studies.Pregabalin for the management of neuropathic pain in spinal cord injury.Pregabalin abuse and dependence in Germany: results from a database query.Pregabalin abuse among opiate addicted patients.Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.The absorption profile of pregabalin in chronic pancreatitis.Pregabalin enhances the antinociceptive effect of oxycodone and morphine in thermal models of nociception in the rat without any pharmacokinetic interactions.
P2860
Q24604809-3D7A55AE-8103-4B0D-B76D-C7303E866948Q26764876-C194B093-9EF3-458A-A01B-D13420E29AF3Q34407163-9E86E5EF-4D17-4E73-9B62-A18E55824D12Q34411257-771C1D6D-85C5-4B2C-82C4-98692EE3D6C2Q34434641-3AAD186D-7754-4BFC-BFEE-C4ED66A70FE5Q34509031-CFF6200A-91D7-4E81-8795-F554489E621BQ34613361-DD237F9A-542F-45BD-98FF-EE51880D8A07Q34756216-7FD4F93C-A103-4FD6-9104-C091B154A32EQ35120597-71CB6EAF-4B37-4528-8009-E57FF8C1F0EBQ36252863-DB5F3319-D647-470C-8C48-50787C8D96C5Q36443685-E2772F1E-6CBB-4221-86C4-68CE968EAD3FQ37530486-B8A0901C-495D-4A05-872B-226C782FFD0AQ37761937-F9EA38C7-816D-438C-9624-6C8DF1DB1437Q37803241-D3424859-FCF5-42AB-8963-A1558C4F78A4Q37965704-AA1F2829-051C-4F7C-A57E-6C05BBDA46E7Q38025453-44AD2477-BE3F-4F94-825F-5F619B31C826Q38027180-68CC150C-36AA-4D17-AFEB-E90DE46D8579Q38058284-D92ACF59-9A5B-483C-A855-847AECAD536EQ38064486-A8E39CD2-B638-4BBB-8982-DA13980925F9Q38075049-B4522C41-6689-4A8F-A025-ED1243ADF787Q38152329-9A56D6C3-7D55-44F9-837D-D30578D18977Q38242390-366D9E25-EFB2-4890-96D9-69D3CEA1C981Q38537865-6BE92A5F-F1D8-4557-9D56-883F90990A66Q38589027-E8AC0907-B4FF-47AD-A80C-FB09614DF1F3Q38877302-92AFDE1E-74AC-4822-8C2F-1B493BE23169Q39079619-B89BDD45-1392-4876-A248-2BAC957D098EQ39085683-F69C01FB-E21D-422B-ABDC-72310C3B583DQ39933211-130AC1D5-AC3D-4DFF-AD77-EE40AA40A9B0Q40057939-FBA7A252-6195-4423-AD1A-9797C2DF7701Q41960088-DB274625-DD13-413D-A509-B10455A0BF29Q41992322-A3A00EC0-1A7F-4B0B-A02D-D148FB1369E2Q42359905-D524BC04-F54E-4DF2-AB53-925246D8A0D7Q42674842-A5E26616-E9A2-422C-93DB-D4AAA9E5A9F2Q42674848-E6EC428A-78D1-499A-9605-4429E83CF55FQ43922422-DB62FE37-2C56-4411-9539-0C4461395EA7Q44066305-8CD975D8-EA3E-41EA-B768-A6D0BCB3EF5EQ44236161-1944B810-8DF9-454E-9CC2-5E918EB970B7Q45413391-662D6956-7443-4604-9E21-C9D945E0BB13Q45720038-66C4CC3F-9FD4-45E0-8CA7-4DB30FBED892Q47696003-BF4A1A63-E965-49A1-B2CA-6F8E4AE84270
P2860
Clinical pharmacokinetics of pregabalin in healthy volunteers.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@en
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@nl
type
label
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@en
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@nl
prefLabel
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@en
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@nl
P2093
P2860
P356
P1476
Clinical pharmacokinetics of pregabalin in healthy volunteers.
@en
P2093
Brian W Corrigan
Christine W Alvey
David L Wesche
Edward J Randinitis
Edward L Posvar
George M Haig
Howard N Bockbrader
James C Strand
Janice A Busch
Louis L Radulovic
P2860
P304
P356
10.1177/0091270009352087
P577
2010-02-10T00:00:00Z